Gilbert A. Fuller Sells 490 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 490 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $44.59, for a total transaction of $21,849.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

USANA Health Sciences Price Performance

USANA Health Sciences stock opened at $45.07 on Thursday. The company’s 50-day moving average is $46.42 and its 200-day moving average is $48.05. The firm has a market capitalization of $865.34 million, a PE ratio of 14.04, a P/E/G ratio of 1.38 and a beta of 0.94. USANA Health Sciences, Inc. has a fifty-two week low of $41.45 and a fifty-two week high of $69.60.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.52 by $0.35. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The company had revenue of $221.08 million during the quarter, compared to the consensus estimate of $206.70 million. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.75 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of USNA. Quest Partners LLC acquired a new stake in shares of USANA Health Sciences during the fourth quarter worth $66,000. CWM LLC increased its position in USANA Health Sciences by 49.6% during the fourth quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after acquiring an additional 420 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in USANA Health Sciences by 60.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after purchasing an additional 1,274 shares during the period. Trexquant Investment LP acquired a new position in shares of USANA Health Sciences during the 4th quarter worth approximately $266,000. Finally, Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences during the third quarter worth approximately $297,000. 54.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on USNA. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th. DA Davidson reduced their price target on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a report on Tuesday.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.